Compare IMUX & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMUX | JILL |
|---|---|---|
| Founded | 2016 | 1959 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.2M | 246.5M |
| IPO Year | 2013 | 2017 |
| Metric | IMUX | JILL |
|---|---|---|
| Price | $14.99 | $16.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $36.00 | $17.00 |
| AVG Volume (30 Days) | ★ 174.0K | 70.7K |
| Earning Date | 05-14-2026 | 06-10-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | ★ $596,549,000.00 |
| Revenue This Year | N/A | $2.65 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $53.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $10.41 |
| 52 Week High | $15.84 | $18.80 |
| Indicator | IMUX | JILL |
|---|---|---|
| Relative Strength Index (RSI) | 59.12 | 66.57 |
| Support Level | $0.74 | $14.93 |
| Resistance Level | $15.81 | $17.14 |
| Average True Range (ATR) | 0.82 | 0.90 |
| MACD | -0.14 | -0.02 |
| Stochastic Oscillator | 51.75 | 77.03 |
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). J.Jill caters to a distinctive set of women, typically forty-five years and older, offering them various apparel products, footwear, and accessories, comprising shirts, dresses, tops and tees, sweaters, pants and jeans, jewelry, bags, belts, shoes, scarves, etc. The company's operating segments consist of its Retail channels, which derive maximum revenue, and Direct channels. Geographically, the majority of its revenue is derived from the United States.